Company Integrative Health Technologies, Inc. Other OTC
Equities
IHTI
US45822A2078
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2009 | Weight | Delta |
---|---|---|---|
Research and Development
100.0
%
| 0 | 100.0 % | - |
Sales per region
USD in Million | 2009 | Weight | Delta |
---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Samuel C. Keith
CIO | Chief Investment Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,642,597 | 19,642,597 ( 48.33 %) | 0 | 48.33 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+2.08% | 42.75B | |
+47.70% | 41.61B | |
+12.39% | 41.34B | |
-12.36% | 26.59B | |
+8.75% | 25.49B | |
-23.35% | 18.12B | |
+30.90% | 12.24B | |
-1.82% | 11.76B | |
+8.72% | 11B |